Trial Profile
A Phase 2 Pilot Study of the Efficacy of ATI-2042 in subjects with Paroxysmal Atrial Fibrillation and Pacemakers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Budiodarone (Primary)
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- 26 Jul 2011 New trial record